Literature DB >> 4858772

The preparation and properties of an antiserum for the radioimmunoassay of serum conjugated cholic acid.

G M Murphy, S M Edkins, J W Williams, D Catty.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4858772     DOI: 10.1016/0009-8981(74)90045-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  7 in total

1.  Aspects of bile acid metabolism in cystic fibrosis.

Authors:  M C Goodchild; G M Murphy; A M Howell; S A Nutter; C M Anderson
Journal:  Arch Dis Child       Date:  1975-10       Impact factor: 3.791

2.  Clinical value of bile salt tests in anicteric liver disease.

Authors:  J G Douglas; G J Beckett; I A Nimmo; N D Finlayson; I W Percy-Robb
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

3.  Physiological factors influencing serum bile acid levels.

Authors:  M Ponz De Leon; G M Murphy; R H Dowling
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

4.  Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.

Authors:  A F Hofmann; G Molino; M Milanese; G Belforte
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

5.  Diurnal serum levels of primary conjugated bile acids. Assessment by specific radioimmunoassays for conjugates of cholic and chenodeoxycholic acid.

Authors:  S W Schalm; N F LaRusso; A F Hofmann; N E Hoffman; G P van Berge-Henegouwen; M G Korman
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

6.  Radioimmunoassay of primary bile salts in serum.

Authors:  Y A Baqir; J Murison; P E Ross; I A Bouchier
Journal:  J Clin Pathol       Date:  1979-06       Impact factor: 3.411

7.  Measurement of serum primary bile acid ratio by gas liquid chromatography and radioimmunoassay.

Authors:  C R Pennington; Y A Baqir; P E Ross; J Murison; I A Bouchier
Journal:  J Clin Pathol       Date:  1979-06       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.